Pattern Pharma Inc.

TORONTO, A6 · Founded 2018 · CIK 0001759778 · Biotech · Private

Phenotypic bacterial identification and antibiotic susceptibility testing (ID/AST) platform

pattern.bio →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$1.2M
7 Form D · Aug 2024
26 months since last filing
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$40,000
Private capital raisedForm D · SEC$75,000
Private capital raisedForm D · SEC$100,000
Private capital raisedForm D · SEC$500,000
Private capital raisedForm D · SEC$50,000
Private capital raisedForm D · SEC$150,000
Private capital raisedForm D · SEC$275,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1100PICCOLO BIOSYSTEMS, INC.——
1101GENTIBIO, INC.——
1102LUXBIOME INC——
1103Pattern Pharma Inc.—$1.2M
1104ANCHORCHEM LLC——
1105Vault Nano Inc——
1106Pretzel Therapeutics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 7 related persons
  • John AbelesDirector
  • Nicholas GloverDirector
  • Nick GloverExecutive Officer
  • Hans KeirsteadDirector
  • Hans KiersteadDirector
  • Mark van Coeverden de GrootDirector · Executive Officer
  • Andrew WilliamsExecutive Officer

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.